| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Ryuji Arakawa CEO | JPX Exchange | JP3126340003 ISIN |
| JP Country | 12,525 Employees | 29 Sep 2026 Last Dividend | 26 Sep 2014 Last Split | - IPO Date |
Alfresa Holdings Corporation is a prominent player in the pharmaceutical and medical device industry, with a broad spectrum of activities that span the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment. The company boasts an international presence, extending its vast array of services and products beyond the domestic market of Japan. Founded in 2003 and headquartered in Tokyo, Japan, Alfresa has strategically positioned itself in the healthcare sector by catering to a wide range of needs, from hospitals and clinics to drug stores and pharmacies. Through its extensive network of subsidiaries, Alfresa Holdings Corporation is dedicated to improving healthcare quality and accessibility by leveraging its deep industry knowledge and expansive product portfolio.
Alfresa plays a crucial role in the wholesale distribution of ethical pharmaceuticals, offering an extensive range of diagnostic reagents and medical devices/equipment. This segment primarily serves hospitals, clinics, and dispensing pharmacies, ensuring that healthcare providers have access to essential medical products for patient care.
In this domain, Alfresa provides a wide array of over-the-counter drugs, health foods, supplements, and additional products. Targeting drug stores and pharmacies, the company supports the self-care practices of consumers by supplying quality self-medication products.
Alfresa not only markets but also engages in the manufacturing of active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. This comprehensive involvement in the product lifecycle enables the company to ensure the highest quality standards and innovations in healthcare products.
The company extends its manufacturing prowess to other entities through contract manufacturing services. This allows Alfresa to collaborate with various partners in the healthcare industry, facilitating the production of pharmaceuticals under contracted terms.
Beyond products, Alfresa Holdings Corporation operates a dispensing pharmacy business along with other medical-related ventures. This diversification ensures that the company can meet a broad spectrum of healthcare needs, contributing to the well-being of communities it serves.